Compare · FEED vs SNN
FEED vs SNN
Side-by-side comparison of ENvue Medical Inc. (FEED) and Smith & Nephew SNATS Inc. (SNN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both FEED and SNN operate in Industrial Specialties (Health Care), so they compete in similar markets.
- SNN is the larger of the two at $13.00B, about 3593.8x FEED ($3.6M).
- SNN has been more active in the news (6 items in the past 4 weeks vs 4 for FEED).
- SNN has more recent analyst coverage (23 ratings vs 0 for FEED).
- Company
- ENvue Medical Inc.
- Smith & Nephew SNATS Inc.
- Price
- $0.41-5.96%
- $30.60-2.55%
- Market cap
- $3.6M
- $13.00B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 4
- 6
- Recent ratings
- 0
- 23
Smith & Nephew SNATS Inc.
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products for surgeons, including instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.
Latest FEED
- ENvue Medical Appoints Chairman of the Board and New Directors, Bringing Clinical, AI Governance and Capital Markets Expertise to Navigation Platform
- SEC Form PRE 14A filed by ENvue Medical Inc.
- SEC Form 8-K filed by ENvue Medical Inc.
- ENvue Medical Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits
- No longer subject to section 1 Glibert Christian Michael sold $144,480 worth of shares (210,000 units at $0.69), closing all direct ownership in the company (SEC Form 4)
- ENvue Medical Launches AI Training Platform Establishing Artificial Intelligence Foundation for Robotic Feeding Tube Navigation
- ENvue Medical Expands into Burn Intensive Care Unit at Major Academic Health Network
- ENvue Medical Announces Publication of Landmark Independent Study Highlighting Significant Safety, Time-, and Cost-Saving Benefits of ENvue Navigation Platform in Multi-Hospital System
- SEC Form EFFECT filed by ENvue Medical Inc.
- SEC Form 424B3 filed by ENvue Medical Inc.
Latest SNN
- Smith+Nephew introduces groundbreaking LYNX™ COBLATION™ Laryngeal Wand for ENT surgeons
- New German expert consensus provides first risk-based recommendations for sNPWT use in closed surgical incisions
- New German expert consensus highlights role for NPWT in mitigating the economic impact of postoperative wound complications
- SEC Form 6-K filed by Smith & Nephew SNATS Inc.
- SEC Form 6-K filed by Smith & Nephew SNATS Inc.
- SEC Form 6-K filed by Smith & Nephew SNATS Inc.
- SEC Form 6-K filed by Smith & Nephew SNATS Inc.
- SEC Form 6-K filed by Smith & Nephew SNATS Inc.
- Fresh Off Its Nasdaq Debut, a Regenerative-Medicine Upstart Is Stacking Its Board With Big-Pharma Firepower
- SEC Form 6-K filed by Smith & Nephew SNATS Inc.